Is Dr. Bryan Trades’s strategy legit? We backtested it.
The claim: “The gap fill strategy: how to make easy money”
Main test: Nasdaq 100 1-min (34 months). Every test is in the table below.
What we found
- Not easy money.
Full test notes, including earlier and shorter tests
- S&P +7R but Nasdaq -44R.
- 3 of 8 versions positive.
Every test we ran
| Strategy | Market | Trades | Win rate | After costs | Versions profitable | Verdict |
|---|---|---|---|---|---|---|
| Gap fade | Nasdaq 100 1-min (34 months) | 399 | 35% | −44.3R | 1/4 | Hype |
| Gap fade | S&P 500 1-min (34 months) | 322 | 35% | +7.4R | 2/4 | Breakeven |
R = multiples of the risk taken on each trade (−1R = one full stop-loss). Results include trading costs.
How we tested it
We turned the rules into code, ran them on years of real prices with trading costs, then re-ran nearby versions of the rules so one lucky setting can’t pass.
The exact entry, stop-loss, exit and filters behind every number on this page.
1-minute Nasdaq 100 and S&P 500 prices, January 2024-November 2026 (34 months, Dukascopy CFD, a stand-in for NQ/ES futures), regular hours (5-minute).
futures ~1 tick slippage + fees (0.75 pt Nasdaq, 0.40 pt S&P)
4 versions per market tested - the full list with settings is in the paid report.
See every version ▾Nearby versions: why one lucky setting can’t pass
For every test we also ran nearby versions of the same rules: different profit targets, stop-losses, time windows, entries or filters. A strategy only counts as real when most of its versions make money after costs, not just the one that was shown in the video.
■ 75%+ of versions profitable ■ 40–74% ■ under 40%
Other channels we tested
in a $10 reportGet the rules →
We test the rules, not the people. Backtest results only; not financial advice. Past results do not guarantee future results.